MedTrace Logo

Comparative Effectiveness of FITs With Colonoscopy

NCT03264898 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3761

Last updated 2024-08-02

No results posted yet for this study

Summary

Colorectal cancer is a preventable and/or a treatable cancer, but at least 43% of the United States population is not up-to-date with screening. Although 90% of colorectal cancer screening is done using colonoscopy, most other countries use fecal immunochemical tests, reserving colonoscopy for those with a positive fecal immunochemical test. This project will provide the foundation for a paradigm shift for colorectal cancer screening in the United States by identifying how well 5 different FITs work for detecting screening relevant neoplasia, thus reducing morbidity and mortality for colorectal cancer.

Conditions

Interventions

DEVICE

Fecal immunochemical test (FIT)

FIT is a type of fecal occult blood test that uses antibodies to hemoglobin to detect blood in stool.

Sponsors & Collaborators

  • University of North Carolina

    collaborator OTHER

  • Texas Tech University Health Sciences Center

    collaborator OTHER

  • Barcey T. Levy

    lead OTHER

Principal Investigators

  • Barcey T Levy, PhD, MD · University of Iowa

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-02
Primary Completion
2023-03-07
Completion
2023-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03264898 on ClinicalTrials.gov